Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The complexities of epidemiology and prevention of gastrointestinal cancers.

Haq S, Ali S, Mohammad R, Sarkar FH.

Int J Mol Sci. 2012 Oct 1;13(10):12556-72. doi: 10.3390/ijms131012556. Review.

2.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

3.

Chemoprevention for colon cancer: new opportunities, fact or fiction?

Terhaar Sive Droste JS, Tuynman JB, Van Dullemen HM, Mulder CJ.

Scand J Gastroenterol Suppl. 2006;(243):158-64. Review.

PMID:
16782636
4.

Aspirin Use on Incidence and Mortality of Gastrointestinal Cancers: Current State of Epidemiological Evidence.

Huang WK, Tu HT, See LC.

Curr Pharm Des. 2015;21(35):5108-15. Review.

PMID:
26369680
5.

Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.

Triantafillidis JK, Nasioulas G, Kosmidis PA.

Anticancer Res. 2009 Jul;29(7):2727-37. Review.

6.

Gastrointestinal cancer: current screening strategies.

Barr H.

Recent Results Cancer Res. 2011;185:149-57. doi: 10.1007/978-3-642-03503-6_9. Review.

PMID:
21822825
7.

The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer.

Sehdev A, O'Neil BH.

Curr Treat Options Oncol. 2015 Sep;16(9):43. doi: 10.1007/s11864-015-0359-z. Review.

PMID:
26187794
8.

Chronic inflammatory bowel disease and cancer.

Pohl C, Hombach A, Kruis W.

Hepatogastroenterology. 2000 Jan-Feb;47(31):57-70. Review.

PMID:
10690586
9.

Prevention of gastrointestinal cancer--the potential role of NSAIDs in colorectal cancer.

Luk GD.

Schweiz Med Wochenschr. 1996 May 11;126(19):801-12. Review.

PMID:
8693304
10.

Diabetes mellitus as a novel risk factor for gastrointestinal malignancies.

Herrigel DJ, Moss RA.

Postgrad Med. 2014 Oct;126(6):106-18. doi: 10.3810/pgm.2014.10.2825. Review.

PMID:
25414939
11.

Chemoprevention of colorectal cancer: ready for routine use?

Arber N, Levin B.

Recent Results Cancer Res. 2005;166:213-30. Review.

PMID:
15648192
12.

Chemoprevention trials of GI cancers in Asia.

Li JW, Tan MT, Ang TL, Teo EK.

Best Pract Res Clin Gastroenterol. 2015 Dec;29(6):967-78. doi: 10.1016/j.bpg.2015.09.014. Epub 2015 Sep 25. Review.

PMID:
26651257
13.

Cyclooxygenase as a target for colorectal cancer chemoprevention.

Moreira L, Castells A.

Curr Drug Targets. 2011 Dec;12(13):1888-94. Review.

PMID:
21158711
14.

Chemoprevention of colorectal cancer.

Gwyn K, Sinicrope FA.

Am J Gastroenterol. 2002 Jan;97(1):13-21. Review.

PMID:
11808936
15.

Diabetes and pancreatic cancer.

Li D.

Mol Carcinog. 2012 Jan;51(1):64-74. doi: 10.1002/mc.20771.

16.

The genetics, epidemiology, and early detection of gastrointestinal cancers.

Young GP, Demediuk BH.

Curr Opin Oncol. 1992 Aug;4(4):728-35. Review.

PMID:
1511028
17.

Nutrition in the prevention of gastrointestinal cancer.

van den Brandt PA, Goldbohm RA.

Best Pract Res Clin Gastroenterol. 2006;20(3):589-603. Review.

PMID:
16782531
18.

Chemoprophylaxis in gastrointestinal tumors.

Zilli M, Iacobelli S.

Eur Rev Med Pharmacol Sci. 2010 Apr;14(4):285-91. Review.

PMID:
20496537
19.

Prevention and early detection of colorectal cancer--new horizons.

Rennert G.

Recent Results Cancer Res. 2007;174:179-87. Review.

PMID:
17302195
20.

[Colorectal cancer and diabetes].

Svacina S.

Vnitr Lek. 2011 Apr;57(4):378-80. Review. Czech.

PMID:
21612063

Supplemental Content

Support Center